Starting Current for Transcutaneous Pacing
Start transcutaneous pacing at 70-80 mA and titrate upward in 5-10 mA increments until electrical and mechanical capture is achieved.
Initial Settings
The evidence consistently demonstrates that most patients require 40-80 mA to achieve capture 1. Research shows:
- Mean threshold of 74 ± 14 mA for ventricular capture in adults 2
- Median current of 70 mA successfully stimulates 95% of patients 3
- Range typically spans 30-110 mA, with median around 55 mA 4
Begin at 70-80 mA rather than starting low, as this falls within the effective range for most patients and minimizes delays in achieving capture during hemodynamically unstable situations 5.
Titration Strategy
If capture is not achieved at 70-80 mA:
- Increase by 10 mA increments every 5-10 seconds
- Continue until you observe both electrical capture (wide QRS on monitor) AND mechanical capture (palpable pulse, improved blood pressure)
- Maximum output is typically 200 mA on most devices
Confirming True Capture
Critical pitfall: The large pacing artifact can obscure the QRS complex and create false appearance of capture 6. You must confirm BOTH:
- Electrical capture: Wide QRS complex followed by distinct ST segment and broad T wave on ECG 1
- Mechanical capture: Palpable arterial pulse, improved blood pressure, pulse oximetry waveform, or ETCO₂ monitoring 5
If the ECG is unclear due to pacing artifact, switch monitoring leads to minimize artifact and maximize QRS visibility, or rely on hemodynamic confirmation (arterial line, pulse palpation, ultrasound) 6.
Special Circumstances Requiring Higher Current
Expect to need higher thresholds (80-110 mA or more) in:
- Emphysema or COPD (increased chest wall impedance) 1
- Pericardial effusion (increased distance from heart) 1
- Positive pressure ventilation (increased thoracic impedance) 1
- Larger body habitus (though evidence shows energy requirements don't strictly correlate with size) 7
Pain Management
Transcutaneous pacing is painful in conscious patients 5. Research shows 33 of 39 patients (84%) experienced moderate to severe pain 3.
- Provide procedural sedation and analgesia immediately after initiating pacing in conscious patients
- Consider fentanyl 50-100 mcg IV plus midazolam 1-2 mg IV, titrated to effect
- This is a bridge therapy—arrange for transvenous pacing if prolonged pacing is anticipated
Clinical Context
The 2025 AHA Guidelines emphasize that transcutaneous pacing should be used for severe symptomatic bradycardia causing shock when atropine fails or IV/IO access is delayed 5. However, recent evidence shows persistent challenges in achieving and maintaining capture, with factors like hypoxia and underlying rhythm predicting failure 5.
Address reversible causes simultaneously—hypoxia, electrolyte abnormalities, and ischemia must be corrected as pacing alone may not succeed if these are present 5.